Related Experiment Video

Updated: Jun 3, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome

Valéria A Gomes1, Carolina S Vieira, Anna L Jacob-Ferreira

  • 1Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, SP 13081-970, Brazil.

Molecular and Cellular Biochemistry
|March 26, 2011
PubMed

Insights

Polycystic ovary syndrome (PCOS) is linked to altered matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) levels, specifically lower TIMP-2 and higher MMP/TIMP ratios. Androgen excess in PCOS may drive these changes.

Area of Science:

  • Endocrinology
  • Biochemistry
  • Reproductive Medicine

Background:

  • Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) play crucial roles in tissue remodeling and are implicated in various disease pathologies.
  • Altered MMP and TIMP profiles have been suggested to be involved in the pathogenesis of polycystic ovary syndrome (PCOS).

Purpose of the Study:

  • To compare plasma levels of MMPs and TIMPs between women with PCOS and healthy controls.
  • To investigate the association between MMP/TIMP levels and the clinical and biochemical characteristics of PCOS.

Main Methods:

  • Plasma concentrations of MMP-2, MMP-8, MMP-9, TIMP-1, and TIMP-2 were measured in 80 PCOS patients and 65 healthy controls.
  • Techniques included gelatin zymography and enzyme-linked immunoassays.
  • Statistical analyses examined correlations with clinical and biochemical features, including testosterone levels.

Main Results:

  • Plasma TIMP-2 levels were significantly lower in PCOS patients compared to controls (P < 0.05).
  • MMP-2/TIMP-2 and MMP-9/TIMP-1 ratios were elevated in PCOS patients (P < 0.05).
  • Testosterone levels positively correlated with the MMP-9/TIMP-1 ratio and negatively with TIMP-2 levels, and were independent predictors of these measures.

Conclusions:

  • The balance between MMPs and TIMPs is altered in women with PCOS.
  • This imbalance is likely influenced by the androgen excess characteristic of PCOS.
  • Specific MMP/TIMP ratios and TIMP-2 levels may serve as potential biomarkers in PCOS management.

More Related Videos

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

A Modified Technique for Inducing Polycystic Ovary Syndrome in Mice04:49

A Modified Technique for Inducing Polycystic Ovary Syndrome in Mice

Published on: July 5, 2024

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...